MEDP beat EPS expectations by 9.56%
Feb 09, 2026, 11:32 PM
0.00%
What does MEDP do
Medpace Holdings, headquartered in Cincinnati, Ohio, offers outsourced clinical development services to the biotechnology and pharmaceutical industries, employing 5,800 staff since its IPO in 2016. The firm specializes in full-service Phase I-IV clinical trial support across North America, Europe, and Asia.
Medpace Holdings (MEDP) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Medpace Holdings's actual EPS was $4.67, beating the estimate of $4.26 per share, resulting in a 9.56% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.